The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 6, 2008, Pages 2390-2401

  Leontiou, Chrysanthia A ^a   Gueorguiev, Maria ^a   Van Der Spuy, Jacqueline ^b   Quinton, Richard ^c   Lolli, Francesca ^a   Hassan, Sevda ^a   Chahal, Harvinder S ^a   Igreja, Susana C ^s   Jordan, Suzanne ^a   Rowe, Janice ^d   Stolbrink, Marie ^e   Christian, Helen C ^e   Wray, Jessica ^a   Bishop Bailey, David ^a   Berney, Dan M ^a   Wass, John A H ^f   Popovic, Vera ^g   Ribeiro Oliveira Jr , Antônio ^h   Gadelha, Monica R ⁱ   Monson, John P ^a   Akker, Scott A ^a   Davis, Julian R E ^j   Clayton, Richard N ^k   Yoshimoto, Katsuhiko ^l   Iwata, Takeo ^l   Matsuno, Akira ^m   Eguchi, Kuniki ⁿ   Musat, Mâdâlina ^o   Flanagan, Daniel ^p   Peters, Gordon ^d   Bolger, Graeme B ^q   Chapple, J Paul ^a   Frohman, Lawrence A ^r   Grossman, Ashley B ^a   Korbonits, Márta ^a   more..

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f CHURCHILL HOSPITAL   (United Kingdom)

^g CLINICAL CENTER OF SERBIA   (Serbia)

^h FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

ⁱ FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^l UNIVERSITY OF TOKUSHIMA   (Japan)

^m TEIKYO UNIVERSITY   (Japan)

ⁿ HIROSHIMA UNIVERSITY   (Japan)

^o CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^p DERRIFORD HOSPITAL   (United Kingdom)

^q UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^r UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^s NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARYL HYDROCARBON RECEPTOR INTERACTING PROTEIN; CARRIER PROTEIN; GROWTH HORMONE; PHOSPHODIESTERASE 4A5; PHOSPHODIESTERASE IV; PROLACTIN;

ADULT; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; ELECTRON MICROSCOPY; FAMILIAL DISEASE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SECRETORY VESICLE;

EID: 45149085453     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2611     Document Type: Article

References (42)

1. Melmed S 2006 Medical progress: acromegaly. N Engl J Med 355:2558-2573
2. Gadelha MR, Prezant TR, Une KN, Glick RP, Moskal SF, Vaisman M, Melmed S, Kineman RD, Frohman LA 1999 Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene. J Clin Endocrinol Metab 84:249-256
3. Yamada S, Yoshimoto K, Sano T, Takada K, Itakura M, Usui M, Teramoto A 1997 Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 82:239-242
4. Daly AF, Jaffrain-Rea ML, Ciccarelli A, Valdes-Socin H, Rohmer V, Tamburrano G, Borson-Chazot C, Estour B, Ciccarelli E, Brue T, Ferolla P, Emy P, Colao A, De Menis E, Lecomte P, Penfornis F, Delemer B, Bertherat J, Wemeau JL, De Herder W, Archambeaud F, Stevenaert A, Calender A, Murat A, Cavagnini F, Beckers A 2006 Clinical characterization of familial isolated pituitary adenomas. J Clin Endocrinol Metab 91:3316-3323
5. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R, Gundogdu S, De Menis E, Makinen MJ, Launonen V, Karhu A, Aaltonen LA 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312:1228-1230
6. Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA 2000 Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12. J Clin Endocrinol Metab 85:707-714
7. Soares BS, Eguchi K, Frohman LA 2005 Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas. J Clin Endocrinol Metab 90:6580-6587
8. Kuzhandaivelu N, Cong YS, Inouye C, Yang WM, Seto E 1996 XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation. Nucleic Acids Res 24:4741-4750
9. Carver LA, Bradfield CA 1997 Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem 272:11452-11456
10. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G, Raverot G, Barlier A, De Herder W, Penfornis A, Ciccarelli E, Estour B, Lecomte P, Gatta B, Chabre O, Sabate MI, Bertagna X, Garcia BN, Stalldecker G, Colao A, Ferolla P, Wemeau JL, Caron P, Sadoul JL, Oneto A, Archambeaud F, Calender A, Sinilnikova O, Montanana CF, Cavagnini F, Hana V, Solano A, Delettieres D, Luccio-Camelo DC, Basso A, Rohmer V, Brue T, Bours V, Teh BT, Beckers A 2007 Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. J Clin Endocrinol Metab 92:1891-1896
11. Toledo RA, Lourenco DM, Jr., Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP, Dahia PL 2007 Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma. J Clin Endocrinol Metab 92:1934-1937
12. Iwata T, Yamada S, Mizusawa N, Golam HM, Sano T, Yoshimoto K 2007 The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clin Endocrinol (Oxf) 66:499-502
13. Bell DR, Poland A 2000 Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. The role of hsp90. J Biol Chem 275:36407-36414
14. Hollingshead BD, Patel RD, Perdew GH 2006 Endogenous hepatic expression of the hepatitis B virus X-associated protein 2 is adequate for maximal association with aryl hydrocarbon receptor-90-kDa heat shock protein complexes. Mol Pharmacol 70:2096-2107
15. Pollenz RS, Dougherty EJ 2005 Redefining the role of the endogenous XAP2 and C-terminal hsp70-interacting protein on the endogenous Ah receptors expressed in mouse and rat cell lines. J Biol Chem 280:33346-33356
16. Pollenz RS, Wilson SE, Dougherty EJ 2006 Role of endogenous XAP2 protein on the localization and nucleocytoplasmic shuttling of the endogenous mouse Ahb-1 receptor in the presence and absence of ligand. Mol Pharmacol 70:1369-1379
17. Bolger GB, Peden AH, Steele MR, MacKenzie C, McEwan DG, Wallace DA, Huston E, Baillie GS, Houslay MD 2003 Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem 278:33351-33363
18. de Oliveira SK, Hoffmeister M, Gambaryan S, Muller-Esterl W, Guimaraes JA, Smolenski AP 2007 Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor. J Biol Chem 282:13656-13663
19. Froidevaux MS, Berg P, Seugnet I, Decherf S, Becker N, Sachs LM, Bilesimo P, Nygard M, Pongratz I, Demeneix BA 2006 The co-chaperone XAP2 is required for activation of hypothalamic thyrotropin-releasing hormone transcription in vivo. EMBO Rep 7:1035-1039
20. Kang BH, Altieri DC 2006 Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J Biol Chem 281:24721-24727
21. Yano M, Terada K, Mori M 2003 AIP is a mitochondrial import mediator that binds to both import receptor Tom20 and preproteins. J Cell Biol 163:45-56
22. Vogel CF, Sciullo E, Li W, Wong P, Lazennec G, Matsumura F 2007 RELB, a new partner of aryl hydrocarbon receptor-mediated transcription. Mol Endocrinol 21:2941-2955
23. Bhayana S, Booth GL, Asa SL, Kovacs K, Ezzat S 2005 The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly. J Clin Endocrinol Metab 90:6290-6295
24. Luccio-Camelo DC, Une KN, Ferreira RE, Khoo SK, Nickolov R, Bronstein MD, Vaisman M, Teh BT, Frohman LA, Mendonca BB, Gadelha MR 2004 Ameiotic recombination in a new isolated familial somatotropinoma kindred. Eur J Endocrinol 150:643-648
25. Hollingshead BD, Petrulis JR, Perdew GH 2004 The aryl hydrocarbon (Ah) receptor transcriptional regulator hepatitis B virus X-associated protein 2 antagonizes p23 binding to Ah receptor-Hsp90 complexes and is dispensable for receptor function. J Biol Chem 279:45652-45661
26. Petrulis JR, Hord NG, Perdew GH 2000 Subcellular localization of the aryl hydrocarbon receptor is modulated by the immunophilin homolog hepatitis B virus X-associated protein 2. J Biol Chem 275:37448-37453
27. Zudaire E, Cuesta N, Murty V, Woodson K, Adams L, Gonzalez N, Martinez A, Narayan G, Kirsch I, Franklin W, Hirsch F, Birrer M, Cuttitta F 2008 The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers. J Clin Invest 118:640-650
28. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, Enjalbert A, Beckers A 2007 Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. J Clin Endocrinol Metab 92:1952-1955
29. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Makinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T, Robledo M, De Menis E, Weil RJ, Wasik A, Zielinski G, Lucewicz O, Lubinski J, Launonen V, Vahteristo P, Aaltonen LA 2007 Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations. Proc Natl Acad Sci USA 104:4101-4105
30. Georgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, Launonen V, Aaltonen LA 2007 Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. Br J Cancer 96:352-356
31. Cazabat L, Libe R, Perlemoine K, Rene-Corail F, Burnichon N, Gimenez-Roqueplo AP, Dupasquier-Fediaevsky L, Bertagna X, Clauser E, Chanson P, Bertherat J, Raffin-Sanson ML 2007 Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. Eur J Endocrinol 157:1-8
32. Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, Magalhaes AV, Azevedo MF, Giacomini LA, Nascimento PP, Nunes RO, Rosa JW, Jaffrain-Rea ML, Bours V, Beckers A 2007 Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. Eur J Endocrinol 157:383-391
33. Stefaneanu L, Kovacs K, Thapar K, Horvath E, Melmed S, Greenman Y 2000 Octreotide effect on growth hormone and somatostatin subtype 2 receptor mRNAs of the human pituitary somatotroph adenomas. Endocr Pathol 11:41-48
34. De Menis E, Prezant TR 2002 Isolated familial somatotropinomas: clinical features and analysis of the MEN1 gene. Pituitary 5:11-15
35. Cozzi R, Montini M, Attanasio R, Albizzi M, Lasio G, Lodrini S, Doneda P, Cortesi L, Pagani G 2006 Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage. J Clin Endocrinol Metab 91:1397-1403
36. Benlian P, Giraud S, Lahlou N, Roger M, Blin C, Holler C, Lenoir G, Sallandre J, Calender A, Turpin G 1995 Familial acromegaly: a specific clinical entity - further evidence from the genetic study of a three-generation family. Eur J Endocrinol 133:451-456
37. Raitila A, Georgitsi M, Karhu A, Makinen MJ, Salmenkivi K, Arola J, Launonen V, Vahteristo P, Aaltonen LA 2007 No evidence of somatic AIP mutations in sporadic endocrine neoplasia. Endocr Relat Cancer 14: 901-906
38. Yu R, Bonert V, Saporta I, Raffel LJ, Melmed S 2006 Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. J Clin Endocrinol Metab 91:5126-5129
39. Digiovanni R, Serra S, Ezzat S, Asa SL 2007 AIP mutations are not identified in patients with sporadic pituitary adenomas. Endocr Pathol 18:76-78
40. Asa SL, Ezzat S 2002 The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836-849
41. Matsuno A, Teramoto A, Yamada S, Kitanaka S, Tanaka T, Sanno N, Osamura RY, Kirino T 1994 Gigantism in sibling unrelated to multiple endocrine neoplasia: case report. Neurosurgery 35:952-955
42. McCarthy MI, Noonan K, Wass JA, Monson JP 1990 Familial acromegaly: studies in three families. Clin Endocrinol (Oxf) 32:719-728